Michael J Weinstein is a Clinical Trial Manager with experience in the field of Hematology. Prior to their current role at CRISPR Therapeutics, Michael J held positions at various pharmaceutical companies such as Sanofi Genzyme, Alnylam Pharmaceuticals, Amgen, and ICOS Corporation. Michael graduated from Central Washington University with a degree in Biology in 2002.
January, 2023 - present
January, 2021
January, 2020
July, 2018
October, 2017
January, 2017